Don Gregory Neeb - Aug 1, 2025 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Signature
/s/ Mary Ann E. Moore, Attorney-in-Fact
Stock symbol
MD
Transactions as of
Aug 1, 2025
Transactions value $
$0
Form type
4
Date filed
8/5/2025, 05:05 PM

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Neeb Don Gregory EVP, Chief Invest & Strategy 1301 CONCORD TERRACE, SUNRISE /s/ Mary Ann E. Moore, Attorney-in-Fact 2025-08-05 0002079487

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Award $0 +81.3K $0.00 81.3K Aug 1, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MD Performance Share Unit Award $0 +320K $0.00 320K Aug 1, 2025 Common Stock 320K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2026, twenty-five percent (25%) of the restricted shares will vest on June 1, 2027 and fifty percent (50%) of the restricted shares will vest on June 1, 2028, subject to the terms of the Plan.
F2 Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both the service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to $16.94, $20.33 and $23.71 for at least 20 consecutive trading days before the third anniversary of the grant date.